|
|
Enron Mail |
RealMoney.com's DAILY BULLETIN
November 21, 2001 http://www.realmoney.com ************************ADVERTISEMENT************************* Privista ***Have you seen your credit report lately?*** Don't let fraud or errors ruin your credit rating. Sign up for Credit Insight, brought to you by TheStreet.com and get unlimited access to your credit report. You'll also receive a credit rating of where you stand and a record of who's looking at your file! Click here to sign up for your FREE credit report today! http://ad.2clk.net/eclk;3606913;1729382257000484863;6593942;202527;;53948 ************************************************************** o Companies in Today's Bulletin: Amgen (AMGN:Nasdaq) Nokia (NOK:NYSE) Northfield Laboratories (NFLD:Nasdaq) ____________________________________ Reality Test: Ben, at His Most Panglossian, Can't Make Sense of the Bulls If the next decade witnesses an unprecedented surge in profit, the markets still end up near bubble levels. http://www.thestreet.com/p/rmoney/bensteinfree/10004265.html ____________________________________ Steven Hendlin: Shrink Rap: Market Misery Loves Company Are you feeling whupped by this market? Join the crowd -- and stop beating yourself up! http://www.thestreet.com/comment/shrinkrap/10004253.html ____________________________________ The Real Deal: Home Front: The Motivational Speaker's Job Gets Heavier Kevin Elko isn't just giving pep talks -- he's talking to brokers about their postattack emotions. http://www.thestreet.com/comment/realdeal/10004246.html ____________________________________ Meet the Street: Not Out of the Woods Yet Lipper analyst Andrew Clark dissects the recent market rally. http://www.thestreet.com/funds/meetthestreet/10004273.html ____________________________________ Biotech Sage: Some Biotech Mutual Funds Worth Considering Nadine Wong is the editor, publisher and co-founder of the monthly BioTech Sage Report. Wong writes a weekly column that appears on this page as part of her business relationship with TheStreet.com. http://www.thestreet.com/funds/biotechsagepf/10004264.html _____________________________________ Biotech/Pharmaceuticals: Amgen Says Pipeline Primed for Next Year The big biotech company says sales of new products will push earnings 20% higher next year. http://www.thestreet.com/stocks/biotech/10004270.html ____________________________________ The Night Watch: Amgen Jumps on Strength of Forecast Analog Devices falls after guiding Wall Street lower. http://www.thestreet.com/markets/nightwatch/10004269.html ____________________________________ James J. Cramer: Bet on Big Buybacks by Banking Behemoths In tough times, stock repurchases can represent banks' best use of capital. http://www.thestreet.com/p/rmoney/jamesjcramer/10004267.html ____________________________________ Wireless Wiz: Nokia's Great Leap Forward The phonemaker unveils a radical design with multimedia messaging, but the rollout could be too slow. http://www.thestreet.com/comment/wirelesswiz/10004250.html ____________________________________ James J. Cramer: Drillers' Estimates Will Run Dry Looking for a new short? Try the oil stocks. JJC sees number cuts imminent here. http://www.thestreet.com/p/rmoney/jamesjcramer/10004262.html ____________________________________ Detox: Little Pink Elephants for You and Me The market thinks the economy is recovering, but really we're all just drunk on easy money. http://www.thestreet.com/markets/detox/10004257.html ____________________________________ Adam Feuerstein: FDA Sends Northfield Back for a Redesign It could be a long and expensive road back to drug regulators for the company's blood substitute. http://www.thestreet.com/tech/adamfeuerstein/10004266.html ____________________________________ Futures Shock: Talking About a Revolution With advantages that single-stock futures offer, you have to wonder why no one thought of them before. http://www.thestreet.com/comment/futures/10004238.html ______________________________________________________________________ November 21 James J. Cramer will host TheStreet.com's radio show "RealMoney with Jim Cramer." The show airs daily from 3-4 p.m. EDT. Got a question for Jim Cramer? Call 1-800-862-8686. ______________________________________________________________________ If you would like to be removed from our bulletin mailing list, or would like to select which of our bulletins you receive, please go to the following URL: http://www.thestreet.com/p/upc/bulletin.jhtml Copyright Notice Except for making one printed copy of this or any other materials, files or documents available from, accessible through or published by TheStreet.com Inc. for your personal use (or downloading for the same limited purpose), these may not be reproduced, republished, broadcast or otherwise distributed without prior written permission of TheStreet.com Inc. For bulk reprints of any article, please contact Brad Glouner at Reprint Management Services, at (717) 399-1900 ext. 130, or via email at bglouner@rmsreprints.com. ____________________________________________________________________ For general comments, questions or suggestions, please send an email to feedback@realmoney.com. For letters about our editorial content intended for publication, please send an email to letters@realmoney.com. Remember to include your full name and city. If you have a question regarding your account, please contact us at members@realmoney.com. ____________________________________________________________________ For TheStreet.com's privacy policy, please click here: http://www.thestreet.com/tsc/about/privacy.html. Email delivery and ad services are provided by DoubleClick's DARTmail. Click here for important privacy information: http://www.privacychoices.org/ ____________________________________________________________________ Copyright 2000 TheStreet.com, Inc. All rights reserved.
|